skip to content

Cipla

Cipla Limited: A Global Pharmaceutical Giant Cipla Limited, headquartered in Mumbai, stands as a prominent multinational pharmaceutical company with a global reach. Its core focus lies in developing and manufacturing medications targeting a wide spectrum of diseases, including respiratory ailments, ...

Cipla Overview

Image Source : Wikipedia
  • Company type Public
  • Industry Pharmaceuticals
  • Founded 1935 (90 years ago) (1935)
  • Founders Khwaja Abdul Hamied
  • Headquarters Mumbai, Maharashtra, India
  • Area served Worldwide
  • Revenue ₹25,455 crore (US$2.9 billion) (FY24)
  • Net income ₹4,106 crore (US$470 million) (FY24)
  • Number of employees 22,036
  • Subsidiaries Invagen Pharmaceuticals
  • Website www.cipla.com

Related Other Pages:

Cipla history

Last Updated : 25/03/25, 11:12 PM
Cipla: A Legacy of Pharmaceutical Innovation Established in Mumbai in 1935 as Chemical, Industrial & Pharmaceutical Laboratories, Cipla, under the stewardship of Khwaja Abdul Hamied, laid the foundation for its enduring legacy. Following Hamied's death in 1972, his son Yusuf Hamied, a Cambridge-...

CIPLA NEWS

Cipla launches HIV/AIDS treatment kit at Rs 158

August 14, 2012 7:01 pm

The kit 'Qvir' consists of two tablets packaged together in one strip which represents a single day's treatment.

Cipla to invest Rs 500 cr to set up API

August 05, 2012 10:47 am

The setting up of these facilities is expected to be complete in 2012-13.

Cipla up over 7%; stock hits 52-wk high

August 01, 2012 11:23 am

Stock of drug major Cipla today surged over 7 per cent to touch one-year high

Cipla’s price cut breached patent rights: Bayer

May 11, 2012 12:36 am

German pharma major Bayer has charged that Indian generic drugmaker Cipla had breached its patent rights by slashing the price of a generic version of its patent-protected cancer drug Nexavar last week.

Demand notices of Rs 2,358 cr issued for drug overcharging

November 25, 2011 5:24 pm

Pharmaceutical firms which have been issued notices include Cipla and Ranbaxy Laboratories.

Fag-end buys buoy Sensex by 44 pts

June 06, 2011 5:16 pm

Sensex managed to rise after last minute buying in IT,banking and capital goods.

Cipla Q4 net down 22.33 pc to Rs 214 cr

May 06, 2011 2:21 am

Drug major Cipla on thursday said its net profit declined by 22.33 per cent to Rs 214 crore for the fourth quarter ended March 31,2011.

Global HIV patients get India boost vs Abbot

January 03, 2011 2:25 pm

Abbot Laboratories patent application on a HIV drug was rejected by Indian courts.

And now,code technology & SMS to counter fake drugs

December 25, 2010 12:43 am

We are in talks with 50 major pharma companies in India to offer our products to identify counterfeit drugs and protect life of the common people.

Unsung heroes add to investor wealth

September 21, 2010 5:32 pm

Just the 30-odd Sensex cos have hogged the limelight,but investor wealth is being created elsewhere too.

Weather
Edition
Install the Express App for
a better experience
Featured
Trending Topics
News
Multimedia
Follow Us